Celestica, Inc. $CLS Shares Sold by Sharpepoint LLC

Sharpepoint LLC decreased its holdings in shares of Celestica, Inc. (NYSE:CLS) (TSE:CLS) by 22.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,030 shares of the technology company’s stock after selling 2,567 shares during the quarter. Celestica makes up approximately 1.6% of Sharpepoint LLC’s holdings, making the stock its 22nd biggest holding. Sharpepoint LLC’s holdings in Celestica were worth $2,669,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Townsquare Capital LLC acquired a new stake in Celestica during the fourth quarter worth about $226,000. J.Safra Asset Management Corp acquired a new position in Celestica during the 4th quarter valued at about $66,000. Deutsche Bank AG boosted its stake in Celestica by 8.0% during the 4th quarter. Deutsche Bank AG now owns 267,722 shares of the technology company’s stock valued at $79,141,000 after purchasing an additional 19,831 shares during the period. Caldwell Investment Management Ltd. acquired a new position in Celestica during the 4th quarter valued at about $2,663,000. Finally, Focus Partners Advisor Solutions LLC boosted its stake in Celestica by 33.5% during the 4th quarter. Focus Partners Advisor Solutions LLC now owns 1,137 shares of the technology company’s stock valued at $336,000 after purchasing an additional 285 shares during the period. Institutional investors and hedge funds own 67.38% of the company’s stock.

Insider Activity

In other news, Director Michael Max Wilson sold 4,168 shares of the business’s stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the sale, the director owned 24,718 shares in the company, valued at $8,238,756.58. The trade was a 14.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 1.10% of the stock is owned by corporate insiders.

Celestica Trading Down 2.1%

Shares of NYSE:CLS opened at $363.89 on Thursday. The company has a 50 day moving average of $371.02 and a 200-day moving average of $323.43. The firm has a market cap of $41.84 billion, a P/E ratio of 44.00, a P/E/G ratio of 0.87 and a beta of 2.02. Celestica, Inc. has a twelve month low of $122.03 and a twelve month high of $474.02. The company has a current ratio of 1.26, a quick ratio of 0.73 and a debt-to-equity ratio of 0.36.

Celestica (NYSE:CLS) (TSE:CLS) last released its earnings results on Monday, April 27th. The technology company reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.08. Celestica had a net margin of 6.95% and a return on equity of 36.91%. The business had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. During the same period in the previous year, the firm earned $1.20 EPS. The business’s revenue for the quarter was up 52.8% on a year-over-year basis. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. As a group, analysts anticipate that Celestica, Inc. will post 9.5 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. UBS Group boosted their target price on shares of Celestica from $355.00 to $400.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. TD boosted their target price on shares of Celestica from $330.00 to $350.00 and gave the company a “hold” rating in a research note on Monday, April 20th. Stifel Nicolaus set a $445.00 target price on shares of Celestica in a research note on Tuesday, April 28th. Barclays boosted their target price on shares of Celestica from $391.00 to $441.00 and gave the company an “overweight” rating in a research note on Wednesday, April 29th. Finally, Wolfe Research raised shares of Celestica to a “strong-buy” rating in a research note on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $427.42.

About Celestica

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.